Sensorion and EVEON collaborating on injection system to deliver gene therapy inner ear treatments
Sensorion and EVEON are collaborating on the design and development of an injection system for…
Sensorion and EVEON are collaborating on the design and development of an injection system for…
Sensorion has announced that the first patient has been enrolled in its phase 2a proof…
Sensorion has announced that the US Food and Drug Administration (FDA) has granted rare pediatric…
Biotech company, Sensorion, today (October 24) announced that the initiation of a proof of concept…
The European Medicines Agency (EMA) through its Committee for Orphan Medicinal Products (COMP) has adopted…
On this week’s podcast, our guests are Jeremy Skillington, CEO of Poolbeg Pharma; Dani Bach,…
Biopharma company Mogrify Limited, and Japanese regenerative medicine firm Astellas Pharma Inc., have announced a…
Approval has been granted by the Australian authorities to allow a French company to progress…